International Journal of Infertility & Fetal Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  15 (2024)
Volume  14 (2023)
Volume  13 (2022)
Volume  12 (2021)
Volume  11 (2020)
Volume  10 (2019)
Volume  9 (2018)
Volume  8 (2017)
Volume  7 (2016)
Volume  6 (2015)
Volume  5 (2014)
Volume  4 (2013)
Volume  3 (2012)
Volume  2 (2011)
Volume  1 (2010)
Related articles

VOLUME 15 , ISSUE 2 ( May-August, 2024 ) > List of Articles

RESEARCH ARTICLE

Evaluation of Sleep Disturbances in Women with Polycystic Ovary Syndrome

Nandita Krishnan, Suganya B, Hemamalini AJ

Keywords : Polycystic ovary syndrome, Sleep quality, Eating habits, Lifestyle modification, Psychological disturbance, Insulin resistance

Citation Information : Krishnan N, B S, AJ H. Evaluation of Sleep Disturbances in Women with Polycystic Ovary Syndrome. Int J Infertil Fetal Med 2024; 15 (2):83-92.

DOI: 10.5005/jp-journals-10016-1341

License: CC BY-NC 4.0

Published Online: 28-10-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

A physiological function that is vital to life is sleep. The quality of sleep is closely related to both physical and mental health as well as other well-being indicators. The assessment of the health status of polycystic ovary syndrome (PCOS) should prioritize sleep quality as well as the best methods for preventing these illnesses and enhancing the quality of life (QoL) for such patients. Sleep disturbance may be a crucial aspect of PCOS. Depression, increased insulin resistance, obesity, irregular menstrual cycles, and skin-related diseases are all linked to poor sleep in PCOS patients. Aim: Studying and raising awareness of sleep problems in women with polycystic ovarian syndrome was the goal of this investigation. The purpose of this study was to determine the relationship between sleep disorders and PCOS utilizing a questionnaire. Objectives: The goals of this study were to use a questionnaire to determine the relationship between sleep disruptions and PCOS and to identify the factors that contribute to both conditions. A random sample of women from the Chennai area was used to explore sleep patterns and issues. The study's 70 total individuals were recruited between October 2020 and December 2020. The Pittsburgh Sleep Quality Index (PSQI) and an eating habits questionnaire were combined to create a Google Form. For the purpose of analyzing the sample, statistical analysis was done. Results and discussion: According to Pearson correlation, eating habits and sleep quality are significantly correlated at p = 0.01, σ two-tailed. Conclusion: This investigation came to the conclusion that there is a relationship between PCOS women's food habits and sleep hygiene. Therefore, engaging in physical activity, eating a nutritious diet, and making other lifestyle changes will help people with PCOS sleep better.

HTML PDF Share
  1. Albu D, Albu A. The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients. Endocrine 2019;63(1):157–163. DOI: 10.1007/s12020-018-1756-4
  2. Amiri M, Nahidi F, Yarandi RB, et al. Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial. Health Qual Life Outcomes 2020;18(1):293. DOI: 10.1186/s12955-020-01544-4
  3. Angin P, Yoldemir T, Atasayan K. Quality of life among infertile PCOS patients. Arch Gynecol Obstet 2019;300(2):461–467. DOI: 10.1007/s00404-019-05202-z
  4. Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers 2016;2:16057. DOI: 10.1038/nrdp.2016.57
  5. Barrea L, Marzullo P, Muscogiuri G, et al. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutr Res Rev 2018;31(2):291–301. DOI: 10.1017/S0954422418000136
  6. Barrea L, Arnone A, Annunziata G, et al. Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients 2019;11(10). DOI: 10.3390/nu11102278
  7. Behboodi Moghadam Z, Fereidooni B, Saffari M, et al. Polycystic ovary syndrome and its impact on Iranian women's quality of life: a population-based study. BMC Womens Health 2018;18(1):164. DOI: 10.1186/s12905-018-0658-1
  8. Bellver J, Rodríguez-Tabernero L, Robles A, et al. Polycystic ovary syndrome throughout a woman's life. J Assist Reprod Genet 2018;35(1):25–39. DOI: 10.1007/s10815-017-1047-7
  9. Ganie MA, Vasudevan V, Wani IA, et al. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019 Oct;150(4):333–344. doi: 10.4103/ijmr.IJMR_1937_17. PMID: 31823915; PMCID: PMC6902362.
  10. Naz MSG, Tehrani FR, Majd HA, et al. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. Int J Reprod Biomed. 2019 Sep 3;17(8):533–542. doi: 10.18502/ijrm.v17i8.4818. PMID: 31583370.
  11. Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med 2018;40(3):239–246. DOI: 10.4103/IJPSYM.IJPSYM_561_17
  12. Christ JP, Vanden Brink H, Brooks ED, et al. Ultrasound features of polycystic ovaries relate to degree of reproductive and metabolic disturbance in polycystic ovary syndrome. Fertil Steril 2015;103(3):787–794. DOI: 10.1016/j.fertnstert.2014.12.094
  13. Çoban ÖG, Tulacı ÖD, Adanır AS, et al. Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2019;32(6):600–604. DOI: 10.1016/j.jpag.2019.07.008
  14. Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014;29. DOI: 10.1530/EJE-14-0253
  15. Day F, Karaderi T, Jones MR, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet 2018;14(12):e1007813. DOI: 10.1371/journal.pgen.1007813
  16. Dewailly D, Lujan ME, Carmina E, et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2014;20(3):334–352. DOI: 10.1093/humupd/dmt061
  17. Dumesic DA, Oberfield SE, Stener-Victorin E, et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 2015;36(5):487–525. DOI: 10.1210/er.2015-1018
  18. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018;14(5):270–284. DOI: 10.1038/nrendo.2018.24
  19. Fitzgerald S, DiVasta A, Gooding H. An update on PCOS in adolescents. Curr Opin Pediatr 2018;30(4):459–465. DOI: 10.1097/MOP.0000000000000636
  20. Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism 2019;92:108–120. DOI: 10.1016/j.metabol.2018.11.002
  21. Hallajzadeh J, Khoramdad M, Karamzad N, et al. Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res 2018;10(2):56–69. DOI: 10.15171/jcvtr.2018.10
  22. Hamedeh C, Ghazeeri G, Tewfik I. Nutritional management in polycystic ovary syndrome: challenges and opportunities. Int J Food Safety Nutr Public Health 2018;3(2):870–882. DOI: 10.1504/IJFSNPH.2021.113389
  23. Htet T, Cassar S, Boyle JA, et al. Informing translation: the accuracy of information on websites for lifestyle management of polycystic ovary syndrome. Semin Reprod Med 2018;36(1):80–85. DOI: 10.1055/s-0038-1667309
  24. Kakoly NS, Earnest A, Teede HJ, et al. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care 2019;42(4):560–567. DOI: 10.2337/dc18-1738
  25. Kite C, Lahart IM, Afzal I, et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis. Syst Rev 2019;8(1):51. DOI: 10.1186/s13643-019-0962-3
  26. Kogure GS, Ribeiro VB, Lopes IP, et al. Body image and its relationships with sexual functioning, anxiety, and depression in women with polycystic ovary syndrome. J Affect Disord 2019;253:385–393. DOI: 10.1016/j.jad.2019.05.006
  27. Kshetrimayum C, Sharma A, Mishra VV, et al. Polycystic ovarian syndrome: environmental/occupational, lifestyle factors; an overview. J Turk Ger Gynecol Assoc 2019;20(4):255–263. DOI: 10.4274/jtgga.galenos.2019.2018.0142
  28. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013;98(12):4565–4592. DOI: 10.1210/jc.2013-2350
  29. Lim SS, Hutchison SK, Van Ryswyk E, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2019;3(3):CD007506. DOI: 10.1002/14651858.CD007506.pub4
  30. Marciniak A, Lejman-Larysz K, et al. [Polycystic ovary syndrome - current state of knowledge]. Pol Merkur Lekarski 2018;44(264):296–301. PMID: 30057399.
  31. Mario FM, Graff SK, Spritzer PM. Habitual physical activity is associated with improved anthropometric and androgenic profile in PCOS: a cross-sectional study. J Endocrinol Invest 2017;40(4):377–384. DOI: 10.1007/s40618-016-0570-1
  32. Neven ACH, Laven J, Teede HJ, et al. A Summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med 2018;36(1):5–12. DOI: 10.1055/s-0038-1668085
  33. Teede HJ, Norman RJ, Garad RM. A new evidence-based guideline for assessment and management of polycystic ovary syndrome. Med J Aust 2019;210(6):285–285.e1. DOI: 10.5694/mja2.50053
  34. Pastoor H, Timman R, de Klerk C, et al. Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biomed Online 2018;37(6):750–760. DOI: 10.1016/j.rbmo.2018.09.010
  35. Rubin KH, Glintborg D, Nybo M, et al. Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2017;102(10):3848–3857. DOI: 10.1210/jc.2017-01354
  36. Rzońca E, Bień A, Wdowiak A, et al. Determinants of quality of life and satisfaction with life in women with polycystic ovary syndrome. Int J Environ Res Public Health 2018;15(2). DOI: 376 10.3390/ijerph15020376
  37. Saleem F, Rizvi SW. New therapeutic approaches in obesity and metabolic syndrome associated with polycystic ovary syndrome. Cureus 2017;9(11):e1844. DOI: 10.7759/cureus.1844
  38. Saslow LR, Aikens JE. Lifestyle interventions for polycystic ovary syndrome: cross-sectional survey to assess women's treatment and outcome preferences. JMIR Form Res 2020;4(9):e17126. DOI: 10.2196/17126
  39. Shannon M, Wang Y. Polycystic ovary syndrome: a common but often unrecognized condition. J Midwifery Womens Health 2012;57(3):221–230. DOI: 10.1111/j.1542-2011.2012.00161.x
  40. Shorakae S, Ranasinha S, Abell S, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf) 2018;89(5):628–633. DOI: 10.1111/cen.13808
  41. Stapinska-Syniec A, Grabowska K, Szpotanska-Sikorska M, et al. Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome. Gynecol Endocrinol 2018;34(7):597–600. DOI: 10.1080/09513590.2018.1427713
  42. Tay CT, Moran LJ, Wijeyaratne CN, et al. Integrated model of care for polycystic ovary syndrome. Semin Reprod Med 2018;36(1):86–94. DOI: 10.1055/s-0038-1667310
  43. Terry NL, Ryan ME. Polycystic ovary syndrome (PCOS). 2012.
  44. Toosy S, Sodi R, Pappachan JM. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. J Diabetes Metab Disord 2018;17(2):277–285. DOI: 10.1007/s40200-018-0371-5
  45. Management of obesity in adolescents with polycystic ovary syndrome. Expert Opin Pharmacother 2020;21(2):207–211. DOI: 10.1080/14656566.2019.1701655
  46. Veltman-Verhulst SM, Boivin J, Eijkemans MJ, et al. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update 2012;18(6):638–651. DOI: 10.1093/humupd/dms029
  47. Walters KA, Gilchrist RB, Ledger WL, et al. New perspectives on the pathogenesis of PCOS: neuroendocrine origins. Trends Endocrinol Metab 2018;29(12):841–852. DOI: 10.1016/j.tem.2018.08.005
  48. Wolf WM, Wattick RA, Kinkade ON, et al. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health 2018;15(11). DOI: 10.3390/ijerph15112589
  49. Witchel SF, Oberfield S, Rosenfield RL, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr 2015. DOI: 10.1159/000375530
  50. Zhang Z, Hong Y, Chen M, et al. Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome. Metabolomics 2020;16(2):20. DOI: 10.1007/s11306-020-1642-y
  51. CR Kothari. Research Methodology Methods and Techniques. Second Revised Edition. New Age International Publishers; 2004; pp. 125–147.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.